In 2016, when Erin Schanning lost her brother Ethan to an overdose, she was surprised to learn that there were “many evidence-based ways to treat substance use disorder that he hadn’t had access to, even though he had doggedly pursued treatment.” Now one of those treatments, buprenorphine, is about to become much more widely available.